{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:22:57Z","timestamp":1715991777305},"reference-count":7,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pharm. Pat. Anal."],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.4155\/ppa-2020-0011","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T12:08:40Z","timestamp":1592309320000},"page":"75-76","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Three Drugs Facing Key Patent Expirations and Potential Generic Entry From June 2020 to July 2020"],"prefix":"10.1080","volume":"9","author":[{"given":"Yali","family":"Friedman","sequence":"first","affiliation":[{"name":"DrugPatentWatch\rWashington\rDistrict of Columbia\r20009\rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,6,16]]},"reference":[{"key":"e_1_3_3_2_1","unstructured":"Friedman Y . Generic drug launch dates \u2013 A 1-step solution to navigate the web of drug patents and regulatory protections (2020). https:\/\/www.drugpatentwatch.com\/blog\/generic-drug-launch-dates-a-1-step-solution-to-navigate-the-web-of-drug-patents-and-regulatory-protections"},{"key":"e_1_3_3_3_1","unstructured":"Friedman Y . QSYMIA drug profile (2020). https:\/\/www.drugpatentwatch.com\/p\/tradename\/QSYMIA"},{"key":"e_1_3_3_4_1","unstructured":"VIVUS INC .: US7674776B2 (2006)."},{"key":"e_1_3_3_5_1","unstructured":"Friedman Y . DENAVIR drug profile (2020). https:\/\/www.drugpatentwatch.com\/p\/tradename\/DENAVIR"},{"key":"e_1_3_3_6_1","unstructured":"BEECHAM GROUP PLC .: US5075445A (1991)."},{"key":"e_1_3_3_7_1","unstructured":"Friedman Y . TECFIDERA drug profile (2020). https:\/\/www.drugpatentwatch.com\/p\/tradename\/TECFIDERA"},{"key":"e_1_3_3_8_1","unstructured":"BIOGEN IDEC INTERNATIONAL GMBH . US7619001B2 (2009)."}],"container-title":["Pharmaceutical Patent Analyst"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/ppa-2020-0011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T18:41:49Z","timestamp":1715971309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/ppa-2020-0011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["10.4155\/ppa-2020-0011"],"URL":"https:\/\/doi.org\/10.4155\/ppa-2020-0011","relation":{},"ISSN":["2046-8954","2046-8962"],"issn-type":[{"value":"2046-8954","type":"print"},{"value":"2046-8962","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ippa20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ippa20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-08-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2015-11-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}